Intrauterine device
76 results
1 - 76
Expulsion rates of intrauterine devices placed postpartum vary based on several factors- The past use of an intrauterine device is not associated with infertility, but a past Mycoplasma genitalium infection is
- Small increase in risk for breast cancer associated with levonorgestrel-releasing intrauterine device
- Cervical-uterine instillation with mepivacaine modestly reduces pain during intrauterine device insertion
- Women who use levonorgestrel-releasing intrauterine devices are less likely to develop ischemic stroke than nonusers of hormonal contraception
- LNG-IUD is noninferior to copper IUD for emergency contraception
- Levonorgestrel-releasing IUS effective for menorrhagia
- Paracervical block reduces pain with IUD placement
- LNG-IUS effective treatment for mild to moderate endometrial hyperplasia
- Long-acting contraceptive methods effective longer than approved duration
- Immediate insertion after uterine aspiration increases IUD use rate
- Long-acting contraception associated with reduction in repeat abortion
- Postpartum IUD placement at 2-4 wk = 6-8 wk, with caveats
- LNG-IUD more beneficial than systemic progestin to treat complex atypical endometrial hyperplasia in obese women
- Women with endometrial intraepithelial neoplasia have a lower complete response rate but more pregnancies with oral progestins vs levonorgestrel-releasing IUDs
- Long-acting contraception associated with low failure
- Fertility returns within 6 months for more than 50% of the women who stop using contraceptives
- Contraceptive implant and LNG-IUD both reduce pelvic pain associated with endometriosis
- Early postpartum insertion of long-acting reversible contraceptive is associated with fewer pregnancies
- Medication abortion for pregnancy of unknown location a reasonable option
- Low incidence of pregnancy with same-day-start contraception
- Levonorgestrel is ineffective emergency contraception for obese women
- Intracervical block with 2% lidocaine reduces pain associated with LNG-IUS placement
- Certain hormonal contraceptives increase thromboembolism risk when taken with NSAIDs
- Women more likely to use EC with advance provision
- Free contraception associated with reduced long-term pregnancy and birth rates in teens (CHOICE study)
- Natural history of heavy menstrual bleeding in perimenopause
- Access to free LARC associated with decreased risk of unintended pregnancy
- Letrozole is noninferior to mifepristone for the management of missed miscarriage
- Elagolix with add-back therapy effective for premenopausal heavy menstrual bleeding associated with fibroids